The BTHS diagnosis was confirmed by the presence of a TAZ mutation in 18 patients (73%), and the 4 other patients had a presumptive diagnosis based on an informative cardiolipin profile in 1 and clinical signs of BTHS in a proven pedigree in 3. The gene discussed is TAFAZZIN; the disease is Barth syndrome.